(HealthDay News) -- People who carry a certain genetic variant involved in blood clotting and inflammation have a lower five-year survival rate after coronary artery bypass surgery, researchers report.
The findings should be used to better treat and ensure the survival of these surgical patients over the long-term, said the research team from Duke University Medical Center in Durham, N.C.
"There are possibilities that we could apply this information someday to a patient's prognosis, and for careful monitoring or increased surveillance if a person has a 2.5 times higher risk of dying, instead of letting them go their way after a CABG [coronary artery bypass graft] surgery," study senior author Mihai Podgoreanu, an assistant professor of anesthesiology, said in a Duke news release. Read more...
Cardiofy Heart Care Supplement
